"Imidazoline Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors of CLONIDINE and other IMIDAZOLINES. Activity of the ligands was earlier attributed to ADRENERGIC ALPHA-2 RECEPTORS. Endogenous ligands include AGMATINE, imidazoleacetic acid ribotide, and harman.
| Descriptor ID |
D054755
|
| MeSH Number(s) |
D12.776.827.137
|
| Concept/Terms |
Imidazoline Receptors- Imidazoline Receptors
- Receptors, Imidazoline
- Receptors, Imidazoline-Guanidinium
- Receptors, Imidazoline Guanidinium
- Imidazoline-Guanidinium Receptors
- Imidazoline Guanidinium Receptors
|
Below are MeSH descriptors whose meaning is more general than "Imidazoline Receptors".
Below are MeSH descriptors whose meaning is more specific than "Imidazoline Receptors".
This graph shows the total number of publications written about "Imidazoline Receptors" by people in this website by year, and whether "Imidazoline Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 4 | 4 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 13 | 13 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Imidazoline Receptors" by people in Profiles.
-
Maziveyi M, Dong S, Baranwal S, Mehrnezhad A, Rathinam R, Huckaba TM, Mercante DE, Park K, Alahari SK. Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth. Cancer Res. 2019 May 01; 79(9):2152-2166.
-
Piletz J, Baker R, Halaris A. Platelet imidazoline receptors as state marker of depressive symptomatology. J Psychiatr Res. 2008 Jan; 42(1):41-9.
-
Wu N, Su RB, Xu B, Lu XQ, Liu Y, Zheng JQ, Piletz JE, Li J, Qin BY. IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence. Biochem Pharmacol. 2005 Oct 01; 70(7):1079-87.
-
Chan CK, Burke SL, Zhu H, Piletz JE, Head GA. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Neuroscience. 2005; 132(4):991-1007.
-
Halaris A, Piletz JE. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci. 2003 Dec; 1009:1-20.
-
Zhu H, Halaris A, Piletz JE. Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections. Ann N Y Acad Sci. 2003 Dec; 1009:296-301.
-
Ma JK, Zhu HE, Piletz JE. Effect of postmortem delay on imidazoline receptor-binding proteins in human and mouse brain. Ann N Y Acad Sci. 2003 Dec; 1009:341-6.
-
Zhu H, Piletz JE. Association between I(2) binding sites and monoamine oxidase-B activity in platelets. Ann N Y Acad Sci. 2003 Dec; 1009:347-52.
-
Piletz JE, Wang G, Zhu H. Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue. Ann N Y Acad Sci. 2003 Dec; 1009:392-9.
-
Dontenwill M, Piletz JE, Chen M, Baldwin J, Pascal G, Ronde P, Dupuy L, Greney H, Takeda K, Bousquetd P. IRAS is an anti-apoptotic protein. Ann N Y Acad Sci. 2003 Dec; 1009:400-12.